<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for Thorpewood Medical Group</h1>
        <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
            explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to: identify unusual prescribing, collect feedback on this prescribing to inform development of new tools to support
            prescribers and organisations to audit and review prescribing.</p>
        <p>The below reports have been developed to use “z-scores” to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. It is important to remember that
            this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical
            method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a> but briefly we calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator.
            We used the time period from 1 April 2021 to 1 August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs. From this we can calculate the “z-score”, which is a measure
            of how many standard deviations a given practice/CCG/PCN is from the population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier
            for prescribing lower than its peers.</p>
        <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=+">survey</a>            or emailing us at
            <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed
            feedback.
        </p>
        <h2>Prescribing where Thorpewood Medical Group is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82048&amp;numIds=0402010P0&amp;denomIds=4.2.1&amp;selectedTab=summary">Pericyazine</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>390</td>
      <td>Antipsychotic drugs</td>
      <td>1658</td>
      <td>0.24</td>
      <td>0.00</td>
      <td>0.02</td>
      <td>11.97</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82048&amp;numIds=0402010P0AAADAD&amp;denomIds=4.2.1&amp;selectedTab=summary" target="_blank">Pericyazine 2.5mg tablets : 310</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82048&amp;numIds=0402010P0AAAEAE&amp;denomIds=4.2.1&amp;selectedTab=summary" target="_blank">Pericyazine 10mg tablets : 80</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82048&amp;numIds=0212000AK&amp;denomIds=2.12&amp;selectedTab=summary">Bempedoic acid</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>6</td>
      <td>Lipid-regulating drugs</td>
      <td>6543</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>10.06</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82048&amp;numIds=0212000AKBBAAAA&amp;denomIds=2.12&amp;selectedTab=summary" target="_blank">Nilemdo 180mg tablets : 6</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82048&amp;numIds=0704020G0&amp;denomIds=7.4.2&amp;selectedTab=summary">Flavoxate hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>29</td>
      <td>Drugs for urinary frequency enuresis and incontinence</td>
      <td>638</td>
      <td>0.05</td>
      <td>0.00</td>
      <td>0.01</td>
      <td>7.65</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82048&amp;numIds=0704020G0AAACAC&amp;denomIds=7.4.2&amp;selectedTab=summary" target="_blank">Flavoxate 200mg tablets : 29</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82048&amp;numIds=0205052AD&amp;denomIds=2.5.5&amp;selectedTab=summary">Azilsartan medoxomil</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>3</td>
      <td>Angiotensin-II receptor antagonists</td>
      <td>1726</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>4.64</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82048&amp;numIds=0205052ADAAAAAA&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Azilsartan medoxomil 20mg tablets : 3</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82048&amp;numIds=0601023AE&amp;denomIds=6.1.2&amp;selectedTab=summary">Linagliptin</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>411</td>
      <td>Other antidiabetic drugs</td>
      <td>705</td>
      <td>0.58</td>
      <td>0.16</td>
      <td>0.11</td>
      <td>3.95</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82048&amp;numIds=0601023AEAAAAAA&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Linagliptin 5mg tablets : 411</a></div></td></tr></tbody></table>

        <h2>Prescribing where Thorpewood Medical Group is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82048&amp;numIds=1001010P0&amp;denomIds=10.1.1&amp;selectedTab=summary">Naproxen</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>425</td>
      <td>Non-steroidal anti-inflammatory drugs</td>
      <td>1063</td>
      <td>0.40</td>
      <td>0.69</td>
      <td>0.10</td>
      <td>-2.85</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAIW0lEQVR4nO2dfYwdVRmHn6GFWlrXogVKguVYDagEUtC0qfhVMYU6tSlQ0FQDwWKDBorRxE4b8SOROKUIxZVQUGqrUVGprdihYCBVsbbBIBIgRUScVTFYqdAPpYDy+sd7aLbX3XXXnTPn3jvvk9zcu232/t679z5zZs5950wiIhiG0QwOi12AYRj1YcIbRoMw4Q2jQZjwhtEgTHjDaBAmvGE0CBPeMBqECW8YDcKEN4wGYcIbRoMw4UOSJNa3bLQVY2MXYBituKw4AjgDOBs4CXg1MBHYAzwN9AE7gYeB35R5+nykUjuOxE6eCUiSCCJJ7DI6BZcVk4FPABcBvwLuAh4EdgP7gUnAZGAa8EbgVGA6ugG4C9gIPFTmqX2oB8GED4kJPyz8iL4MuAT4OtBb5umzw/zdBN0LSIFzgKOANcD6Mk/3hqm4czHhQ2LC/09cVswCbgLuBVaUebpnlM/3BuBjwPnAt4FryjzdPepCuwQTPiQm/KC4rBgLXImK+dEyT7dV/Pw9wBXoXsMtwKoyT5+rMqMTMeFDYsIPiMuKqcB3gEeBK8o8/UfArKOAzwDz0cOGjU0+xjfhQ2LC/xcuK85Ej9OXl3l6a425bwJWA2PQjcwjdWW3EyZ8SEz4g/jJtU8BFwMXxBDO1zAfuBr4EfDZMk8P1F1HTEz4kJjwALisGAP0Aq9HZR/VxFwF9YwHvgi8F7iwzNMHY9ZTJyZ8SEx4XFYciR6vPwMsKfP0xcglHcRlxWzgZnRC7+bY9dSBCR+ShgvvG2luB+4GPteOk2UuK44GbgWeAC7v9l18Ez4kDRbeZcU0YDOwut1HT/8VYQ7MAOYPt+mnEzHhQ9JQ4V1WvBX4Pjob/uPY9QwXlxWXo9/bv6/M0ydj1xMCEz4kDRTeZcVc4Abgg2We3he7npHisuIC4Cp0pN8Zu56qMeFD0jDhXVZcina3vb/M08dj1/P/4rLiPWh33qIyT7fHrqdKTPiQNER4fwx8HXAKcF439K67rDgNuA24rMzTLbHrqQpbAMMYFS4rjkNPTR0HzOkG2QHKPH0AmAOsdllxfux6qsJG+JB0+QjvsuIs4EbgC2Wero9dTwhcVhyPbtBWlXm6LnI5o8aED0mXCu+y4lXASmAmepzbdZNb/XFZcQxwJ7C2zNOvxq5nNNguvTEiXFbMA+4H/gTM6HbZAco83QWcCXzIZcXy2PWMBhvhQ9JFI7zvSLseOAG4pAmit+KyYiJ60s196GIdHSePCR+SLhDen/iyGFgBfBm4oczTl+JWFQ+XFa8AfoCuo7e00/4WJnxIOlx4v/xUL/AY8OkyT/8cuaS2wGXF4cC3gOeBxWWe/ityScPGhA9JhwrvsmIK2ls+HW2P/VnkktoOv+dzE7po5qJOWSrbhA9JhwnvsmIS8EngQuAaYE0njV514xfUuBZdMnthyKW6qsKED0mHCO9H9I+j68GvA67r5jPGqsRLvwI4D1hQ5ukfI5c0JCZ8SNpYeP9BfRt6dths4GvoiN4VnXJ147JiIbp01ofLPP1l7HoGw4QPSZsJ7yU/GR2NPgD8BVgLbOiUY9B2xmXF6cB3gW8AV7fjDL4JH5I2EN5Lfhoq+bnoUlMbgNvKPO2LWVs34rsQbwSOQWfw2+pvbMKHJJLwfgZ5JnrppXOAJ9EzvzbaV2vh8RvZRehCmb3AV9pl8tOED0mNwvuR5SxgHnpM/giwCdhU5ulTddRgHIpf028VcDqwHNgSuzvPhA9JQOH9KHIiKniKLgH9E3QduXvKPN0fItcYOX7Jr5XouStXoe9PFPFM+JBULLzv5X47OpKnwLOo4AXwQDtOEhmK30DPBjL0evfXo5Ol/6yzDhM+JKMU3l8QcQb6QZkNHA9sQ5d9LmxXvTPxs/mXAnOBO4AfAlvLPH0hdLYJH5IhhHdZMQ54DTC53+044HXo7vnJwEvAr4GfAluBR2MfAxrV4bJiArDA32ah7/U2YAewE/hb1e+3CT8EfrZ7ItADvLLfrWeQx4f8XK6cN8Mt2/w7dPmnI1qe/gXg6ZbbX4E/oBdF2Fnm6d6Qr89oH/wA8Bb0kG0mcBI6IPQBvwV+DzyFfkYO3kZ6SDAi4f3iBy+PWO12PwYYCxw+wH3/x+OAI4HxLff9H4/zz/tvYD+wD9jr7/cN8POA/1eunNfnlm3uQc+qetFGZ2Mk+AFnKir/NOBYYIq/f/nx+DJPpwz7SUUk2g1YYnmWZ3n15cVe4mqJ5Vme5dWXF1t4wzBqxIQ3jAYRW/i6rypqeZbX6Dz7Ws4wGkTsEd4wjBoZW3dgkiTvRFda2SUia5MkuQjtKtsiIltryJuLnh/+kIhUfu3y1jz/b2uAdSKyI3RekiSfR3vs7xCRxwJnvQPtENshIj+vMmuIzAXAm4HxInJl4KzFaBMVIrK6yqxB8j4CTAL6RGRD1XkQZ4SfJSI5cDSAiKwH1qCNBcHz0LbF1wIH6shLkuRctDU2FK2vbzcwoaas+cBzaAtwKFo/L5vQrrPvhc5Cm7mOBXYFyBoob6qIXAucHSgvivCHTBokSTIBvdDBN+vIE5FngMsIt4FpnRQ5FW2XPKOOPBHpBb4ELAydBfT4vDkBsgbLBDhFRB6uIeswEVmOntsQgta8e5IkWQrsCZRX/6Sd342ZBfwdPVlgKfA4cLeIbK8hbzr6Bu4QkdtD54nI/UmSvBs4EHCXvv/rOxE9RPqFiNwZOOsEwAF7ROSWKrOGyHwCuNiPhKGz3oW2WO8Tkcpn0AfIm4j20W8XkXurzgObpTeMRmGz9IbRIEx4w2gQJrxhNAgT3jAahAlvGA3ChDeMBmHCG0aDMOENo0GY8IbRIEx4w2gQJrxhNIj/AB+wZTCPQ+NLAAAAAElFTkSuQmCC"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82048&amp;numIds=1001010P0AAADAD&amp;denomIds=10.1.1&amp;selectedTab=summary" target="_blank">Naproxen 250mg tablets : 77</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82048&amp;numIds=1001010P0AAAEAE&amp;denomIds=10.1.1&amp;selectedTab=summary" target="_blank">Naproxen 500mg tablets : 266</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82048&amp;numIds=1001010P0AAAHAH&amp;denomIds=10.1.1&amp;selectedTab=summary" target="_blank">Naproxen 250mg gastro-resistant tablets : 53</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82048&amp;numIds=1001010P0AAAIAI&amp;denomIds=10.1.1&amp;selectedTab=summary" target="_blank">Naproxen 500mg gastro-resistant tablets : 29</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82048&amp;numIds=0501021L0&amp;denomIds=5.1.2&amp;selectedTab=summary">Cefalexin</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>91</td>
      <td>Cephalosporins</td>
      <td>130</td>
      <td>0.70</td>
      <td>0.96</td>
      <td>0.10</td>
      <td>-2.54</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82048&amp;numIds=0501021L0AAABAB&amp;denomIds=5.1.2&amp;selectedTab=summary" target="_blank">Cefalexin 500mg capsules : 44</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82048&amp;numIds=0501021L0AAANAN&amp;denomIds=5.1.2&amp;selectedTab=summary" target="_blank">Cefalexin 125mg/5ml oral suspension sugar free : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82048&amp;numIds=0501021L0AAADAD&amp;denomIds=5.1.2&amp;selectedTab=summary" target="_blank">Cefalexin 250mg/5ml oral suspension : 9</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82048&amp;numIds=0501021L0AAAAAA&amp;denomIds=5.1.2&amp;selectedTab=summary" target="_blank">Cefalexin 250mg capsules : 18</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82048&amp;numIds=0501021L0AAACAC&amp;denomIds=5.1.2&amp;selectedTab=summary" target="_blank">Cefalexin 125mg/5ml oral suspension : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82048&amp;numIds=0501021L0AAAGAG&amp;denomIds=5.1.2&amp;selectedTab=summary" target="_blank">Cefalexin 250mg tablets : 11</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82048&amp;numIds=0501021L0AAAPAP&amp;denomIds=5.1.2&amp;selectedTab=summary" target="_blank">Cefalexin 250mg/5ml oral suspension sugar free : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82048&amp;numIds=0704010U0&amp;denomIds=7.4.1&amp;selectedTab=summary">Tamsulosin hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>677</td>
      <td>Drugs for urinary retention</td>
      <td>877</td>
      <td>0.77</td>
      <td>0.92</td>
      <td>0.06</td>
      <td>-2.40</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82048&amp;numIds=0704010U0AAAAAA&amp;denomIds=7.4.1&amp;selectedTab=summary" target="_blank">Tamsulosin 400microgram modified-release capsules : 652</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82048&amp;numIds=0704010U0AAABAB&amp;denomIds=7.4.1&amp;selectedTab=summary" target="_blank">Tamsulosin 400microgram modified-release tablets : 22</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82048&amp;numIds=0704010U0BMAAAA&amp;denomIds=7.4.1&amp;selectedTab=summary" target="_blank">Contiflo XL 400microgram capsules (Ranbaxy) : 3</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82048&amp;numIds=0104020L0&amp;denomIds=1.4.2&amp;selectedTab=summary">Loperamide hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>144</td>
      <td>Antimotility drugs</td>
      <td>148</td>
      <td>0.97</td>
      <td>1.00</td>
      <td>0.01</td>
      <td>-2.10</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82048&amp;numIds=0104020L0AAAAAA&amp;denomIds=1.4.2&amp;selectedTab=summary" target="_blank">Loperamide 2mg capsules : 140</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82048&amp;numIds=0104020L0AAABAB&amp;denomIds=1.4.2&amp;selectedTab=summary" target="_blank">Loperamide 1mg/5ml oral solution sugar free : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82048&amp;numIds=0104020L0AAADAD&amp;denomIds=1.4.2&amp;selectedTab=summary" target="_blank">Loperamide 2mg tablets : 3</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82048&amp;numIds=1310012F0&amp;denomIds=13.10.1&amp;selectedTab=summary">Fusidic acid</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>24</td>
      <td>Antibacterial preparations also used systemically</td>
      <td>56</td>
      <td>0.43</td>
      <td>0.72</td>
      <td>0.15</td>
      <td>-1.92</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D82048&amp;numIds=1310012F0AAABAB&amp;denomIds=13.10.1&amp;selectedTab=summary" target="_blank">Fusidic acid 2% cream : 24</a></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>